Marubeni Global Pharma Achieves Milestone in Business Integration with Sumitomo Dainippon Pharma
2 week ago / Read about 0 minute
Author:小编   

Sumitomo Dainippon Pharma announced on August 1 the successful completion of the first phase of its equity transfer and the divestiture of related assets. Consequently, the former Sumitomo Dainippon Pharma China has officially been separated from Sumitomo Dainippon Pharma Co., Ltd. and integrated into the Marubeni Group. This marks a significant achievement for Marubeni Global Pharma, who has successfully acquired a portion of Sumitomo Dainippon Pharma's business operations in China.